


OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda presents Phase 2/3 study results for TAK-881 in primary immunodeficiency (PID), showing comparability to HYQVIA with 50% less IG volume.

The Invesco International Dividend Achievers ETF retains a Sell rating due to persistent underperformance and elevated risk metrics versus international benchmarks. PID's strategy of targeting dividend growers lacks a quality screen, resulting in weak dividend growth and total return relative to the benchmark ACWX. The fund's high expense ratio (0.53%) and heavy Canadian concentration undermine its appeal for international diversification.

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the MIUD

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in Primary Immunodeficiency Disease (PID) patients, met its primary endpoint.

BCS Wealth Management increased its stake in Invesco International Dividend Achievers ETF (NASDAQ: PID) by 100.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 54,698 shares of the company's stock after purchasing an additional 27,349 shares during the period. BCS Wealth Management owned

Osaic Holdings Inc. lowered its position in Invesco International Dividend Achievers ETF (NASDAQ: PID) by 6.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 322,602 shares of the company's stock after selling 23,525 shares during the quarter. Osaic Holdings

Invesco International Dividend Achievers ETF (NASDAQ: PID - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Friday. The stock traded as high as $22.22 and last traded at $22.21, with a volume of 29955 shares changing hands. The stock had previously closed at $21.93. Invesco International Dividend Achievers ETF